Rampart Investment Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Rampart Investment Management's GILD Position: Q4 2020 in Review
Rampart Investment Management sold out of Gilead Sciences (GILD) in Q4 2020, closing a stake of 7,761 shares — an estimated $490K sold.
Rampart Investment Management first reported a position in GILD in Q1 2017 and held it in 15 quarters. The position peaked at $2.64M in Q1 2018. 1,564 funds tracked by Wall St. Rank hold GILD as of Q4 2020.
- Rampart Investment Management reported no remaining Gilead Sciences position as of Q4 2020 after selling out during the quarter.
- Rampart Investment Management sold 7,761 Gilead Sciences shares in Q4 2020, an estimated $490K.
- Rampart Investment Management first reported a position in Gilead Sciences in Q1 2017 and held it in 15 quarters.
- Rampart Investment Management's Gilead Sciences position peaked at $2.64M in Q1 2018.
- 1,564 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2020.
Based on Rampart Investment Management's 13F filing for Q4 2020.